Concepedia

Author

Oliver Jonas

Brigham and Women's HospitalORCID

Also Known As

Jonas, Oliver, O JONAS, O. Jonas, O.H. Jonas, Oliver H. Jonas, Oliver Jonas, Oliver Jonas*, Wisinski, Kari B.

174

Publications

3.3K

Citations

19

H-Index

59

Concepts

All Affiliations

Brigham and Women's HospitalHarvard UniversityMassachusetts Institute of TechnologyDana-Farber Cancer InstituteBroad Institute
OJ

About

Oliver Jonas is an author at Brigham and Women's Hospital specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

554

2

Engineering

3

3

109

3

Biomedical Engineering

2

2

82

4

Health Sciences

1

1

18

5

Biochemistry

1

1

14

Oliver Jonas

×

25

Publications

3.2K

Citations

19

H-Index

YearCitations

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Leore T. Geller, Michal Barzily-Rokni, Tal Danino,

Science

2017

1.7K

Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors

Shawn M. Davidson, Oliver Jonas, Mark A. Keibler,

Nature Medicine

2016

326

Tumor Cell–Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression

Madeleine J. Oudin, Oliver Jonas, Tatsiana Kosciuk,

Cancer Discovery

2016

211

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors

Oliver Jonas, Heather M. Landry, Jason Fuller,

Science Translational Medicine

2015

186

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

Spencer S. Watson, Mark Dane, Koei Chin,

Cell Systems

2018

99

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis

Seiji Arai, Oliver Jonas, Matthew A. Whitman,

Clinical Cancer Research

2018

68

Invasive cancer cell lines exhibit biomechanical properties that are distinct from their noninvasive counterparts

Oliver Jonas, Claudia Tanja Mierke, Josef A. Käs

Soft Matter

2011

65

Integrated genetic and pharmacologic interrogation of rare cancers

Andrew L. Hong, Yuen‐Yi Tseng, Glenn S. Cowley,

Nature Communications

2016

55

REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks

Nimrat Chatterjee, Matthew A. Whitman, Cynthia Harris,

Proceedings of the National Academy of Sciences

2020

53

MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer

Madeleine J. Oudin, Lucie Barbier, Claudia Schäfer,

Molecular Cancer Therapeutics

2016

47

Page 1